Northern Trust
RAPP

Northern Trust’s Rapport Therapeutics RAPP Stock Holding History

Northern Trust’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.45M Buy
237,992
+17,177
+8% +$483K ﹤0.01% 2242
2025
Q4 		$6.7M Buy
220,815
+66,958
+44% +$1.85M ﹤0.01% 2302
2025
Q3 		$4.57M Buy
153,857
+37,584
+32% +$670K ﹤0.01% 2551
2025
Q2 		$1.32M Sell
116,273
-11,810
-9% -$125K ﹤0.01% 3233
2025
Q1 		$1.28M Buy
128,083
+55,257
+76% +$717K ﹤0.01% 3167
2024
Q4 		$1.29M Buy
72,826
+614
+0.9% +$13.6K ﹤0.01% 3269
2024
Q3 		$1.48M Buy
+72,212
New +$1.55M ﹤0.01% 3166

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return